Citadel Advisors’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.22M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $5.08M | Buy |
|
|||||
|
2024
Q3 | $167K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $98.9K | Sell |
|
|||||
|
2023
Q4 | $248K | Buy |
|
|||||
|
2023
Q3 | $59K | Sell |
|
|||||
|
2023
Q2 | $144K | Sell |
|
|||||
|
2023
Q1 | $133K | Buy |
|
|||||
|
2022
Q4 | $85.3K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $39K | Buy |
|
|||||
|
2021
Q3 | $25K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $29K | Buy |
|